Key facts
- Lucem Health’s last known valuation is $18.7M (May 2023).
- It has raised $24.4M across 3 recorded rounds; the latest was Early Stage VC ($8.4M) in Mar 2026.
- Notable investors include Mayo Clinic Ventures, Mayo Clinic Platform, Granger Management, Mercy, Commure — 8 tracked in total.
- Lucem Health has filed 2 Form Ds with the SEC since 2023, most recently Jul 2025 ($2.3M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Lucem Health
Funding rounds
3 roundsAbout Lucem Health
Developer of a general-purpose platform intended to help artificial intelligence model developers transform their algorithms into point-of-care alternatives that help clinicians deliver proper care. The company's platform supports the development, deployment, and continuous improvement of clinical artificial intelligence alternatives and ingests clinical data from any source, orchestrates the execution of any model, and delivers insights into clinical workflows, enabling healthcare providers to understand the value and impact the insights are delivering to clinicians and patients.
- Sector
- Healthcare
- HQ
- Davidson, NC, United States
- Founded
- 2021
- Employees
- 39
- Website
- lucemhealth.com/
- Ownership
- Privately Held (backing)
Lucem Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lucem Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lucem Health in its N-PORT filings yet. We sweep new filings monthly.